Hamid Erfanian
2022
In 2022, Hamid Erfanian earned a total compensation of $2.9M as Chief Executive Officer at Enzo Biochem.
Compensation breakdown
| Non-Equity Incentive Plan | $360,000 |
|---|---|
| Option Awards | $1,246,000 |
| Salary | $415,385 |
| Stock Awards | $881,400 |
| Other | $382 |
| Total | $2,903,167 |
Erfanian received $1.2M in option awards, accounting for 43% of the total pay in 2022.
Erfanian also received $360K in non-equity incentive plan, $415.4K in salary, $881.4K in stock awards and $382 in other compensation.
Rankings
In 2022, Hamid Erfanian's compensation ranked 1,250th out of 5,739 executives tracked by ExecPay. In other words, Erfanian earned more than 78.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,250 out of 5,739 | 78th |
Division Services | 361 out of 1,077 | 67th |
Major group Health Services | 24 out of 95 | 75th |
Industry group Medical And Dental Laboratories | 5 out of 38 | 87th |
Industry Medical Laboratories | 5 out of 38 | 87th |
Source: SEC filing on December 20, 2022.
Erfanian's colleagues
We found three more compensation records of executives who worked with Hamid Erfanian at Enzo Biochem in 2022.